T

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Vice President Medical Affairs - Americas

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • An advanced scientific, healthcare, or medical degree, such as a PharmD, PhD, or MD, is required.
  • At least 10 years of experience in biotech, pharma, or related areas is required.
  • At least 5 years in a leadership role is required.
  • Ability to travel 50–75% regionally; international travel may also be requested.
  • Comprehensive knowledge of medical affairs activities, pivotal trials, and the medical landscape of prostate, renal, and neuro-oncology.
  • Experience in a pharmaceutical environment with strong knowledge of the relevant compliance and regulatory environment.
  • Experience with package insert development and trial designs for expanded access programs and registries.
  • Demonstrated ability to lead and influence a US Medical Affairs team in a matrix structure through vision and strategy setting.
  • Demonstrated business acumen, people-management ability, and leadership skills, including the ability to manage complex technical organizations.
  • Demonstrated ability to execute results through leading others while leading by example.
  • Ability to build successful relationships and develop partnerships with business partners and investigators.
  • Strong interpersonal, written, and verbal communication skills, organization, and cross-functional collaboration skills.
  • Strong multitasking, attention to detail, and organizational consistency.

Responsibilities

  • Define Medical Affairs strategy and goals with executive Americas leadership and cross-functional global matrix teams.
  • Oversee Medical Affairs operations, budget, and tactical execution while maintaining excellence, policies, and procedures.
  • Advance collaborations with key opinion leaders and establish and execute strategic scientific-engagement plans for healthcare practitioners, research groups, and centers of excellence.
  • Lead strategy and tactical execution across assets and manage Medical Directors and their direct reports, including field medical liaisons and clinical theranostic specialists.
  • Develop clinical trial recruitment strategies supporting timely Phase 1–Phase 4 registrational trials, expanded access programs, and lifecycle management.
  • Lead Medical Affairs strategy and execution across the Americas in alignment with commercial, marketing, corporate, clinical-pipeline, and product-launch objectives.
  • Support launches of Illuccix, Zircaix, and Pixclara through clinical mindshare, regional publication and data-gap needs, investigator-initiated trial strategy and execution, reader training, medical-information follow-up, and regional standard response letters.
  • Stay current with guidelines and key publications to inform clinical efficacy positioning, and provide competitive-intelligence training to the Medical Affairs team.
  • Develop and oversee communication plans for internal and external stakeholders.
  • Provide clinical strategy input to marketing-material development, sales training, and medical review in Veeva for internal and external stakeholders.
  • Lead scientific-engagement strategy with key opinion leaders, healthcare providers, and professional societies, and deliver medical education and scientific communication.
  • Develop regional metrics for key opinion leader engagement across guidelines, institutions, and subspecialties; use data to inform cross-functional strategies and decisions.
  • Lead publication and congress strategy and execution, including preparing speakers for podium presentations.
  • Support expansion of theranostic clinical practice through evidence generation, data-gap identification and dissemination, collaborative partnerships, and field intelligence that informs medical and clinical strategy.
  • Identify data gaps relating to payors, healthcare-provider needs, guidelines, and societies; lead publication strategy and timelines with medical communications.
  • Develop clinical trial recruitment strategies and metrics, work with clinical operations to identify site and patient-accrual gaps, and support timely trial milestones.
  • Drive medical and scientific meetings and site-engagement meetings; lead advisory boards in collaboration with development teams; support investigator meetings with clinical operations; and integrate findings into cross-functional lifecycle-management strategies.
  • Lead investigator-initiated research strategy and matrix alignment across development, regulatory, clinical, and marketing teams.
  • Apply knowledge of pivotal trial designs and investigator brochures, and review and inform protocol design from a Medical Affairs perspective using field trends and key opinion leader feedback.
  • Maintain a high-performing team through performance coaching, team-performance metrics, and team meetings.
  • Set team subject-matter-expert training, expectations, and metrics across the portfolio, literature, key trials, and competitive intelligence, including Telix investor presentations and competitors.
  • Maintain team knowledge of local pharmaceutical regulations and ensure implementation of Telix policies and procedures; ensure Medical Science Liaison activities comply with objectives, policies, legal requirements, and ethical standards.
  • Work with clinical development, clinical operations, marketing, market access, global medical communications, pharmacovigilance, and commercial stakeholders to provide Medical Affairs input to product development and launch strategies across the Americas.

Desired Qualifications

  • Expertise in prostate, renal, and neuro-oncology radiopharmaceuticals is strongly preferred.

About the Company

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Telix Pharmaceuticals develops and commercializes diagnostic and therapeutic products that use targeted radiation to diagnose and treat cancer and rare diseases. Its pipeline covers urologic oncology (prostate and kidney cancers), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. The treatments work by delivering targeted radiation to diseased tissues, enabling more precise decisions for treatment and allowing for personalized therapy. The company differentiates itself through a global, robust supply chain and a focus on integrating diagnostic and therapeutic options to address unmet medical needs, along with strong commitments to patient care, ethical practices, and environmental responsibility. Telix’s goal is to improve quality of life and outcomes for patients by providing targeted, clinically meaningful diagnostic and therapeutic solutions that support better treatment decisions and personalized care.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Melbourne VIC, Australia
Founded
2015

Recently Posted Jobs

Explore more opportunities at Telix Pharmaceuticals

See more jobs